Home/Filings/4/0001209191-21-050033
4//SEC Filing

Varadan Anand 4

Accession 0001209191-21-050033

CIK 0001339469other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 5:46 PM ET

Size

15.8 KB

Accession

0001209191-21-050033

Insider Transaction Report

Form 4
Period: 2021-08-05
Varadan Anand
Chief Commercial Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-08-0536,0690 total
    Exercise: $1.52Common Stock (36,069 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-08-05105,0000 total
    Exercise: $4.55Common Stock (105,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-08-0513,6920 total
    Exercise: $3.75Common Stock (13,692 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-08-05112,4410 total
    Exercise: $4.84Common Stock (112,441 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-08-05425,0000 total
    Exercise: $4.43Common Stock (425,000 underlying)
Footnotes (2)
  • [F1]This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated as of May 4, 2021, by and among Chiasma, Inc. (the "Company), Amryt Pharma plc ("Parent"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent ("Merger Sub") pursuant to which Merger Sub merged with and into the Company (the "Merger") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the "Effective Time").
  • [F2]At the Effective Time, each option to purchase Shares (each a "Company Option") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an "Assumed Stock Option") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio.

Issuer

CHIASMA, INC

CIK 0001339469

Entity typeother

Related Parties

1
  • filerCIK 0001650456

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:46 PM ET
Size
15.8 KB